Key facts
- Notable investors include Unpopular Ventures.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Ziab
- ·The full record, as it builds
Funding rounds
No funding rounds for Ziab are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Ziab
Developer of an artificial intelligence-based biotechnology platform designed for antibody discovery. The company uses AI-based detection technology designed by bioinformaticians and engineers, enabling the medical industry in the discovery of antibodies and research and development in the field of medicine.
- Sector
- Healthcare
- HQ
- Switzerland
- Website
- ziab.com/
- Ownership
- Privately Held (backing)
Ziab doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Ziab shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Ziab in its N-PORT filings yet. We sweep new filings monthly.